In Silico Study Approach on a Series of 50 Polyphenolic Compounds in Plants; A Comparison on the Bioavailability and Bioactivity Data

Molecules. 2022 Feb 19;27(4):1413. doi: 10.3390/molecules27041413.

Abstract

Fifty (50) phytocompounds from several subclasses of polyphenols, chosen based on their abundance in the plant world, were analyzed through density functional methods, using computational tools to evaluate their oral availability and particular bioactivity on several cell modulators; key descriptors and molecular features related to the electron density and electrostatic potential for the lowest energy conformers of the investigated molecules were computed. An analysis of the bioactivity scores towards six cell modulators (GPCR ligand, ion channel modulator, kinase inhibitor, nuclear receptor ligand, protease inhibitor and enzyme inhibitor) was also achieved, in the context of investigating their potential side effects on the human digestive processes. Summarizing, computational results confirmed in vivo and in vitro data regarding the high bioavailability of soy isoflavones and better bioavailability of free aglycones in comparison with their esterified and glycosylated forms. However, by a computational approach analyzing Lipinski's rule, apigenin and apigenin-7-O-rhamnoside, naringenin, hesperetin, genistein, daidzin, biochanin A and formonetin in the flavonoid series and all hydroxycinnamic acids and all hydroxybenzoic acids excepting ellagic acid were proved to have the best bioavailability data; rhamnoside derivatives, the predominant glycosides in green plants, which were reported to have the lowest bioavailability values by in vivo studies, were revealed to have the best bioavailability data among the studied flavonoids in the computational approach. Results of in silico screening on the phenolic derivatives series also revealed their real inhibitory potency on the six parameters studied, showing a remarkable similitude between the flavonoid series, while flavonoids were more powerful natural cell modulators than the phenyl carboxylic acids tested. Thus, it can be concluded that there is a need for supplementation with digestive enzymes, mainly in the case of individuals with low digestive efficiency, to obtain the best health benefits of polyphenols in humans.

Keywords: GPCR ligand; bioactivity; enzyme inhibitor; in silico study; ion channel modulator; kinase inhibitor; nuclear receptor ligand; oral bioavailability; plant phenolics; protease inhibitor.

Publication types

  • Comparative Study

MeSH terms

  • Biological Availability
  • Computer Simulation*
  • Databases, Factual*
  • Humans
  • Phytochemicals* / chemistry
  • Phytochemicals* / pharmacokinetics
  • Phytochemicals* / therapeutic use
  • Polyphenols* / chemistry
  • Polyphenols* / pharmacokinetics
  • Polyphenols* / therapeutic use

Substances

  • Phytochemicals
  • Polyphenols